Early β‐amyloid accumulation in the brain is associated with peripheral T cell alterations

Author:

Gericke Christoph1,Kirabali Tunahan1,Flury Roman2,Mallone Anna13,Rickenbach Chiara1,Kulic Luka14,Tosevski Vinko5,Hock Christoph167,Nitsch Roger M.17,Treyer Valerie168,Ferretti Maria Teresa19,Gietl Anton1610

Affiliation:

1. Institute for Regenerative Medicine – IREM University of Zurich Schlieren Switzerland

2. Institute of Mathematics University of Zurich Zurich Switzerland

3. Institute of Microbiology ETHZ Zurich Switzerland

4. Roche Pharma Research and Early Development Roche Basel Switzerland

5. Mass Cytometry Facility University of Zurich Zurich Switzerland

6. Center for Prevention and Dementia Therapy University of Zurich Schlieren Switzerland

7. Neurimmune AG Schlieren Switzerland

8. Department of Nuclear Medicine University Hospital Zurich Zurich Switzerland

9. Women's Brain Project Guntershausen Switzerland

10. Psychiatric University Hospital Zurich (PUK) Zurich Switzerland

Abstract

AbstractINTRODUCTIONFast and minimally invasive approaches for early diagnosis of Alzheimer's disease (AD) are highly anticipated. Evidence of adaptive immune cells responding to cerebral β‐amyloidosis has raised the question of whether immune markers could be used as proxies for β‐amyloid accumulation in the brain.METHODSHere, we apply multidimensional mass‐cytometry combined with unbiased machine‐learning techniques to immunophenotype peripheral blood mononuclear cells from a total of 251 participants in cross‐sectional and longitudinal studies.RESULTSWe show that increases in antigen‐experienced adaptive immune cells in the blood, particularly CD45RA‐reactivated T effector memory (TEMRA) cells, are associated with early accumulation of brain β‐amyloid and with changes in plasma AD biomarkers in still cognitively healthy subjects.DISCUSSIONOur results suggest that preclinical AD pathology is linked to systemic alterations of the adaptive immune system. These immunophenotype changes may help identify and develop novel diagnostic tools for early AD assessment and better understand clinical outcomes.

Funder

Universität Zürich

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Velux Stiftung

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3